COVID-19 has slammed the door on most in-person rep meetings for pharmaceutical and device marketers more decisively than ever before. With many new and familiar hurdles, now is the time for today’s life science marketers to rethink their strategy and embrace digital.
At MERGE, we understand these evolving challenges, and are prepared to help navigate this careful transition. In our white paper, Opening Digital Doors: The New Normal of HCP Engagement, we explore the critical role of digital channels in your marketing and sales efforts.
Our POV
Click here to read the full white paper, Opening Digital Doors: The New Normal of HCP Engagement.
